Results
21,284 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 24 | Beatty Jonathan SMD, Head of Advisor Services |  SCHWSCHWAB CHARLES CORPOpen-market sale · 10b5-1 plan | SELL | $301K 3,072 sh | Nov 14, 2025 traded Nov 12, 2025 | |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 24 | Beatty Jonathan SMD, Head of Advisor Services | SCHWSCHWAB CHARLES CORP Open-market sale · 10b5-1 plan | SELL | $301K 3,072 sh | Nov 14, 2025 traded Nov 12, 2025 | |
Lampert DarrenDirector, CEO |
 GRWGGrowGeneration Corp.Open-market sale |
| SELL |
| $122K 70.3K sh |
| Nov 14, 2025 traded Nov 12, 2025 |
| 24 | Ragosa MarkCHIEF FINANCIAL OFFICER |  KNSAKiniksa Pharmaceuticals International, plcOpen-market sale · 10b5-1 plan | SELL | $815K 19.9K sh | Nov 14, 2025 traded Nov 12, 2025 |
| 23 | Reeve EmmaDirector |  PTCTPTC THERAPEUTICS, INC.Open-market sale · 10b5-1 plan | SELL | $546K 7,333 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 23 | Randhawa SimratEVP, Head of R&D |  DNTHDianthus Therapeutics, Inc. /DE/Open-market sale · 10b5-1 plan | SELL | $701K 18.6K sh | Nov 14, 2025 traded Nov 13, 2025 |
| 22 | Gassert ChadSVP - CORP. DEV. & STRATEGY |  ANIPANI PHARMACEUTICALS INCOpen-market sale | SELL | $8,272 94 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 22 | Busse BrianGENERAL COUNSEL |  ARLOArlo Technologies, Inc.Open-market sale · 10b5-1 plan | SELL | $2.15M 149.5K sh | Nov 14, 2025 traded Nov 14, 2025 |
| 22 | Pickering EvanGeneral Counsel |  APPFAPPFOLIO INCOpen-market sale · 10b5-1 plan | SELL | $81K 334 sh | Nov 14, 2025 traded Nov 14, 2025 |
| 22 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $4.16M 109.0K sh | Nov 14, 2025 traded Nov 14, 2025 |
| 21 | Ferguson Kevin WVP, Controller,Chief Acct.Off. |  SLVMSylvamo CorpOpen-market sale | SELL | $46K 1,000 sh | Nov 14, 2025 traded Nov 14, 2025 |
| 20 | Lampert DarrenDirector, CEO | GRWGGrowGeneration Corp. Open-market sale | SELL | $91K 56.5K sh | Nov 14, 2025 traded Nov 13, 2025 |
| 19 |  Farquhar ScottDirector, 10% Owner |  TEAMAtlassian CorpOpen-market sale · 10b5-1 plan | SELL | $485K 3,186 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 19 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $485K 3,186 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 19 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $937K 26.2K sh | Nov 14, 2025 traded Nov 13, 2025 |
| 18 |  Armstrong BrianDirector, Chairman and CEO, 10% Owner |  COINCoinbase Global, Inc.Open-market sale · 10b5-1 plan | SELL | $179K 553 sh | Nov 14, 2025 traded Nov 10, 2025 |
| 16 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $100K 650 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 16 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $136K 868 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 16 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $198K 1,276 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 16 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $100K 650 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 16 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $237K 1,535 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 16 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $198K 1,276 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 16 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $237K 1,536 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 16 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $135K 867 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 14 | Greenstreet YvonneDirector, Chief Executive Officer |  ALNYALNYLAM PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $1.55M 3,406 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 14 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $1.11M 2,420 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 13 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $24K 150 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 13 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $24K 150 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 12 | Ellingson Alan WayneChief Financial Officer |  DKNGDraftKings Inc.Open-market sale · 10b5-1 plan | SELL | $246K 8,421 sh | Nov 14, 2025 traded Nov 14, 2025 |
| 12 | Das SouvikChief Technology Officer |  CWANClearwater Analytics Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $203K 10.0K sh | Nov 14, 2025 traded Nov 12, 2025 |
| 12 | Das SouvikChief Technology Officer | CWANClearwater Analytics Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $201K 10.0K sh | Nov 14, 2025 traded Nov 12, 2025 |
| 11 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $958K 2,132 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 11 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $485K 1,069 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 11 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $547K 1,210 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 11 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $276K 604 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 11 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $566K 1,255 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 11 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $319K 711 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 11 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $891K 1,960 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 11 | Nguyen DianeEVP, Chief Legal Officer & GC |  QBTSD-Wave Quantum Inc.Open-market sale · 10b5-1 plan | SELL | $473K 20.0K sh | Nov 14, 2025 traded Nov 13, 2025 |
| 10 | Cook MeredithSR. VP, GENERAL COUNSEL & SEC. | ANIPANI PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $35K 400 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 9 | Katz ZacharyGC and Head of Global Affairs |  GRNDGrindr Inc.Open-market sale · 10b5-1 plan | SELL | $198K 13.8K sh | Nov 14, 2025 traded Nov 13, 2025 |